Apolipoprotein E ϵ4 in inclusion body myositis
- 1 December 1995
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 38 (6), 957-959
- https://doi.org/10.1002/ana.410380619
Abstract
The genetic predisposition to inclusion body myositis (IBM) is probably multifactorial. The deposition of the β-amyloid protein is a characteristic histological feature of both IBM and Alzheimer's disease (AD). The ϵ4 allele of apolipoprotein E (APO E) has been strongly associated with familial and late-onset AD. We therefore compared the APO E allele frequencies in a group of 14 patients with IBM with those in a group of patients with other inflammatory muscle diseases and in the general population. The frequency of the ϵ4 allele in IBM was increased (0.29) compared with that in patients with other inflammatory muscle diseases (0.15) and the general population (0.13) (p < 0.05). These data suggest that APO E genotype may be one of the factors involved in determining the predisposition to the development of IBM.Keywords
This publication has 18 references indexed in Scilit:
- Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseasesThe Lancet, 1994
- Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseasesThe Lancet, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 1993
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscleNeuroReport, 1993
- Inclusion body myositis: an underdiagnosed condition?Annals Of The Rheumatic Diseases, 1993
- Apolipoprotein ∈4 homozygosity in young men with coronary heart diseaseThe Lancet, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell‐mediated cytotoxicity and muscle fiber necrosisAnnals of Neurology, 1988